Simplex Trading, LLC Navidea Biopharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$0.24 - $0.34 $24 - $34	-100 Reduced 0.35%	28,416 $7,000
Q4 2022 Feb 02, 2023	BUY	$0.18 - $0.3 $1,710 - $2,850	9,500 Added 49.96%	28,516 $5,000
Q3 2022 Nov 04, 2022	SELL	$0.24 - $0.71 $2,544 - $7,526	-10,600 Reduced 35.79%	19,016 $4,000
Q2 2022 Aug 03, 2022	BUY	$0.63 - $1.1 $15,981 - $27,903	25,367 Added 597.01%	29,616 $21,000
Q1 2022 May 02, 2022	SELL	$0.72 - $1.2 $10,381 - $17,302	-14,419 Reduced 77.24%	4,249 $3,000
Q4 2021 Feb 23, 2022	BUY	$1.0 - $1.82 $5,489 - $9,989	5,489 Added 41.65%	18,668 $18,000
Q2 2021 Aug 12, 2021	BUY	$1.55 - $2.15 $20,427 - $28,334	13,179 New	13,179 $24,000
Q1 2021 Apr 26, 2021	SELL	$1.99 - $2.9 $23,392 - $34,089	-11,755 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$1.88 - $2.84 $17,779 - $26,857	-9,457 Reduced 44.58%	11,755 $25,000
Q3 2020 Oct 14, 2020	BUY	$2.69 - $4.95 $6,660 - $12,256	2,476 Added 13.22%	21,212 $57,000
Q2 2020 Jul 13, 2020	BUY	$0.7 - $4.16 $13,115 - $77,941	18,736 New	18,736 $73,000
Q4 2019 Feb 05, 2020	SELL	$0.65 - $1.26 $1,300 - $2,520	-2,000 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$0.5 - $0.91 $1,000 - $1,820	2,000 New	2,000 $1,000

10.4K

Ticker NAVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,150,900
Description
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.